Literature DB >> 9501961

Low bone density with normal bone turnover in ovariectomized and streptozotocin-induced diabetic rats.

S Herrero1, O M Calvo, C García-Moreno, E Martín, J I San Román, M Martín, J R García-Talavera, J J Calvo, J del Pino-Montes.   

Abstract

Diabetes and estrogen deficit are known causes of osteopenia, diabetes being associated with a low bone turnover and estrogen deficit with a high bone turnover. In the present work, we studied the effect of combined ovariectomy and diabetes on bone mineral content (BMC) and bone mineral density (BMD) and several bone markers in the rat. Four groups of rats were studied: control (C), ovariectomized (O), diabetic (D), and ovariectomized and diabetic (DO). Twelve weeks after starting the experiments, BMC and BMD of the first six lumbar vertebrae were measured; a bone formation marker (BGP) and a bone resorption marker (free collagen cross-links, PYD) were also analyzed. Diabetic rats showed diminished gain in bone mass, BMC (D: 0.417 +/- 0.028 g, DO: 0.422 +/- 0.020 g) and BMDs (D: 0.171 +/- 0.006 g/cm2, DO: 0.174 +/- 0.006 g/cm2) both being significantly (P < 0.001) lower than those of control (C: BMC 0.727 +/- 0.024 g and BMD 0.258 +/- 0.004 g/cm2) and ovariectomized (O: BMC 0.640 +/- 0.044 g and BMD 0.240 +/- 0.009 g/cm2) groups. Moreover, the BMC and BMD of the C group were significantly (P < 0.05) higher than that of the O group. BGP and PYD levels were significantly (P < 0.01) higher in the O group (BGP: 138.2 +/- 16.8 ng/ml, PYD: 270.2 +/- 17.8 nM/mM) than those found in the control rats (BGP: 44.7 +/- 4.8 ng/ml, PYD: 165.6 +/- 12.5 nM/mM); the D group showed significantly (P < 0.01) lower values (BGP: 27.4 +/- 14.6 ng/ml, PYD: 55.0 +/- 7.4 nM/mM) than those of the control group. The DO group showed similar levels (BGP: 43.4 +/- 5.1 ng/ml, PYD: 146.7 +/- 14.6 nM/mM) to those found in the C group. Although bone marker levels in the O and D groups were in accordance with those expected in these situations, in the DO group the corresponding levels are apparently "normal." Also, the decrease of gain in bone mass observed after combining estrogen deficit and diabetes (DO group) did not seem to be more marked than that caused by diabetes alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501961     DOI: 10.1007/s002239900427

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  15 in total

1.  Hyperglycemia diverts dividing osteoblastic precursor cells to an adipogenic pathway and induces synthesis of a hyaluronan matrix that is adhesive for monocytes.

Authors:  Aimin Wang; Ronald J Midura; Amit Vasanji; Andrew J Wang; Vincent C Hascall
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

Review 2.  Bone and glucose metabolism: a two-way street.

Authors:  Katherine J Motyl; Laura R McCabe; Ann V Schwartz
Journal:  Arch Biochem Biophys       Date:  2010-08-01       Impact factor: 4.013

3.  Characteristics of bone turnover, bone mass and bone strength in Spontaneously Diabetic Torii-Lepr fa rats.

Authors:  Shuichi Kimura; Tomohiko Sasase; Takeshi Ohta; Eimei Sato; Mutsuyoshi Matsushita
Journal:  J Bone Miner Metab       Date:  2011-10-27       Impact factor: 2.626

4.  Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

Authors:  Sergiu Botolin; Marie-Claude Faugere; Hartmut Malluche; Michael Orth; Ron Meyer; Laura R McCabe
Journal:  Endocrinology       Date:  2005-05-19       Impact factor: 4.736

Review 5.  Bone Cell Bioenergetics and Skeletal Energy Homeostasis.

Authors:  Ryan C Riddle; Thomas L Clemens
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

6.  Estrogen Deficiency Exacerbates Type 1 Diabetes-Induced Bone TNF-α Expression and Osteoporosis in Female Mice.

Authors:  Sandi Raehtz; Hayley Bierhalter; Daniel Schoenherr; Narayanan Parameswaran; Laura R McCabe
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

7.  Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats.

Authors:  Fernanda Penna Lima Guedes de Amorim; Sócrates Souza Ornelas; Sandoval Felicíssimo Diniz; Aline Carvalho Batista; Tarcília Aparecida da Silva
Journal:  J Mol Histol       Date:  2008-07-01       Impact factor: 2.611

8.  Type I diabetic bone phenotype is location but not gender dependent.

Authors:  Lindsay M Martin; Laura R McCabe
Journal:  Histochem Cell Biol       Date:  2007-07-03       Impact factor: 4.304

9.  Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition.

Authors:  Keertik Fulzele; Ryan C Riddle; Douglas J DiGirolamo; Xuemei Cao; Chao Wan; Dongquan Chen; Marie-Claude Faugere; Susan Aja; Mehboob A Hussain; Jens C Brüning; Thomas L Clemens
Journal:  Cell       Date:  2010-07-23       Impact factor: 41.582

10.  Diabetes, biochemical markers of bone turnover, diabetes control, and bone.

Authors:  Jakob Starup-Linde
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.